Publication & Citation Trends
Most Cited Works
Publications
62 total
1189 Elucidating the effects of chemotherapy and immune checkpoint blockade on the activity of tarlatamab, a DLL3-targeting bispecific T cell engager molecule, in small cell lung cancer preclinical models OA
Cited by 1
Semantic Scholar
TOXICOLOGIC PATHOLOGY OF THE HEPATOBILIARY SYSTEM
Cited by 0
Semantic Scholar
Abstract 6313: Evaluation of a dual CD123-FLT3 BiTE molecule for acute myeloid leukemia
Cited by 0
Semantic Scholar
The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer PDF
Cited by 89
OpenAlex
Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule OA
Cited by 6
Semantic Scholar
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer PDF
Cited by 226
OpenAlex
AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys PDF
Cited by 47
OpenAlex
Preclinical evaluation of AMG 160, a next-generation bispecific T cell engager (BiTE) targeting the prostate-specific membrane antigen PSMA for metastatic castration-resistant prostate cancer (mCRPC).
Cited by 21
OpenAlex
Research Topics
Monoclonal and Polyclonal Antibodies Research
(33)
CAR-T cell therapy research
(22)
Lung Cancer Research Studies
(20)
Prostate Cancer Treatment and Research
(15)
Cytomegalovirus and herpesvirus research
(9)
Frequent Co-Authors
Affiliations
Johannes Gutenberg University Mainz
Bioanalytica (Switzerland)
University Medical Center of the Johannes Gutenberg University Mainz
Amgen (Germany)
Pepscan (Netherlands)